Lv7
5005 积分 2023-10-18 加入
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
1个月前
已完结
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
1个月前
已关闭
Single-Domain Antibody Probe with Low Renal Uptake for Claudin 18.2–Targeted PET Imaging of Gastric Cancer: Preclinical and Pilot Clinical Evaluations
1个月前
已关闭
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
1个月前
已关闭
Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers
3个月前
已完结
Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model
3个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
3个月前
已完结
Dose translation from animal to human studies revisited
4个月前
已完结
[The application of ANXA2 gene knockout mouse models in lung cancer metastasis]
4个月前
已完结
Glypican-3–Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside
4个月前
已完结
皖公网安备34019202002308
